AFC-HD AMS Life Science Co., Ltd. (2927.T)
JPY 806.0
(-0.86%)
JPY 806.0
(-0.86%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 865.28 Million | 1.49 Billion | 2.58 Billion | 1.29 Billion | 1.13 Billion | 1.22 Billion |
| Net Income | 1.54 Billion | 1.23 Billion | 2.15 Billion | 1 Billion | 1.09 Billion | 985.65 Million |
| Depreciation & Amortization | 983.99 Million | 1 Billion | 648.73 Million | 509.38 Million | 473.22 Million | 436.55 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.07 Billion | 482.74 Million | -191.25 Million | -49.07 Million | -114.04 Million | -85.14 Million |
| Other non-cash items | -585.89 Million | -1.23 Billion | -32.59 Million | -165.64 Million | -318.27 Million | -115.44 Million |
| Investing Cash Flow | -1.94 Billion | -1.07 Billion | -274.96 Million | -458.71 Million | -202.21 Million | -850.06 Million |
| Investments in PPE | -1.93 Billion | -957.97 Million | -492.07 Million | -381.26 Million | -546.78 Million | -549.32 Million |
| Acquisitions | -114.14 Million | 2 Million | 1.63 Million | 175 Thousand | 291.19 Million | 549.32 Million |
| Investment purchases | -854.29 Million | -1.19 Billion | -723.07 Million | -873.48 Million | -1.36 Billion | -1.29 Billion |
| Sales/Maturities of investments | 1.1 Billion | 1.58 Billion | 869.47 Million | 796.74 Million | 1.4 Billion | 933.24 Million |
| Other Investing Activities | -146.65 Million | -509.11 Million | 69.07 Million | -887 Thousand | 8.06 Million | -484.04 Million |
| Financing Cash Flow | 1.88 Billion | 1.15 Billion | 2.18 Billion | -574.93 Million | -546.88 Million | 280.16 Million |
| Debt repayment | -379.81 Million | -1.03 Billion | -5.58 Billion | -830.92 Million | -381.04 Million | -2.11 Billion |
| Dividends payments | -385.1 Million | -421.99 Million | -312.51 Million | -350.15 Million | -280.13 Million | -180.99 Million |
| Common Stock Repurchased | -79.56 Million | -288.89 Million | -152.83 Million | -29 Thousand | - | 1.26 Billion |
| Common Stock Issuance | 2.77 Billion | - | 8.29 Billion | 700 Million | - | 1.43 Billion |
| Other Financing Activities | -52.71 Million | 2.9 Billion | -58.83 Million | -93.82 Million | 114.29 Million | -128.44 Million |
| Accounts receivables | -206.17 Million | -332.58 Million | 294.35 Million | -26.32 Million | -105.93 Million | -3.91 Million |
| Accounts payables | -210.83 Million | 447.3 Million | -84.87 Million | 195.01 Million | -191.18 Million | 121.25 Million |
| Inventory | -633.43 Million | 123.42 Million | -361.4 Million | -171.8 Million | -12.69 Million | -253.39 Million |
| Other working capital | -28.34 Million | 244.6 Million | -39.32 Million | -45.95 Million | 195.77 Million | 168.25 Million |
| Cash at beginning of period | 10.25 Billion | 8.66 Billion | 4.17 Billion | 3.9 Billion | 3.52 Billion | 2.87 Billion |
| Cash at end of period | 11.06 Billion | 10.25 Billion | 8.66 Billion | 4.17 Billion | 3.9 Billion | 3.52 Billion |
| Capital Expenditure | -1.93 Billion | -957.97 Million | -492.07 Million | -381.26 Million | -546.78 Million | -549.32 Million |
| Effect of forex changes on cash | 3.79 Million | 16.52 Million | 3.46 Million | 3.08 Million | -5.13 Million | 1000.00 |
| Net cash flow / Change in cash | 804.24 Million | 1.59 Billion | 4.49 Billion | 268.44 Million | 377.69 Million | 651.73 Million |
| Free Cash Flow | -1.07 Billion | 534.44 Million | 2.09 Billion | 917.74 Million | 585.14 Million | 672.29 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 281 Million | 323 Million | 318 Million | 420 Million | 1.54 Billion | 268 Million |
| Depreciation & Amortization | - | - | 245.22 Million | 257.07 Million | 983.99 Million | 250.75 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | -1.07 Billion | - |
| Other non-cash items | -281 Million | -323 Million | -318 Million | -420 Million | -585.89 Million | -268 Million |
| Investing Cash Flow | - | - | - | - | -1.94 Billion | - |
| Investments in PPE | - | - | - | - | -1.93 Billion | - |
| Acquisitions | - | - | - | - | -114.14 Million | - |
| Investment purchases | - | - | - | - | -854.29 Million | - |
| Sales/Maturities of investments | - | - | - | - | 1.1 Billion | - |
| Other Investing Activities | - | - | - | - | -146.65 Million | - |
| Financing Cash Flow | - | - | - | - | 1.88 Billion | - |
| Debt repayment | - | - | - | - | -379.81 Million | - |
| Dividends payments | - | - | - | - | -385.1 Million | - |
| Common Stock Repurchased | - | - | - | - | -79.56 Million | - |
| Common Stock Issuance | - | - | - | - | 2.77 Billion | - |
| Other Financing Activities | - | - | - | - | -52.71 Million | - |
| Accounts receivables | - | - | - | - | -206.17 Million | - |
| Accounts payables | - | - | - | - | -210.83 Million | - |
| Inventory | - | - | - | - | -633.43 Million | - |
| Other working capital | - | - | - | - | -28.34 Million | - |
| Cash at beginning of period | - | - | 11.06 Billion | 10.45 Billion | 10.25 Billion | 10.9 Billion |
| Cash at end of period | - | - | 10.19 Billion | 11.06 Billion | 11.06 Billion | 10.45 Billion |
| Capital Expenditure | - | - | - | - | -1.93 Billion | - |
| Effect of forex changes on cash | - | - | - | - | 3.79 Million | - |
| Net cash flow / Change in cash | - | - | -864.44 Million | 606.74 Million | 804.24 Million | -450.5 Million |
| Free Cash Flow | - | - | 490.44 Million | 514.14 Million | -1.07 Billion | 501.51 Million |
3406
OLYMPTX
CHVKF
HLLPF
HALKB
FBRT